3 nominees · 4 ballot items.
Election of three directors (Conner, Felber, Amundsen); approval of the 2026 Omnibus Incentive Plan; non-binding advisory vote on executive compensation (say-on-pay); and ratification of Crowe LLP as independent auditors for 2026.
To elect Michael Conner, Francis Felber and Nicholas Amundsen to serve as directors for three-year terms (Class II directors).
To approve the 2026 Omnibus Incentive Plan, which would reserve up to 300,000 shares for issuance under equity and cash-based awards to employees, non-employee directors and consultants, replacing prior plan availability upon approval.
This management proposal asks shareholders to approve the 2026 Omnibus Incentive Plan, which authorizes up to 300,000 shares for issuance under a range of equity and cash awards to employees, non-employee directors and consultants. Management seeks shareholder approval to replenish and modernize its long-term incentive vehicle so that equity-based awards can be granted in future years (and to allow the Committee to transition from phantom stock to actual equity awards if approved). The filing frames the Plan as important to recruiting, retaining and aligning key talent with stockholder value and describes governance controls: a fixed share pool (no evergreen), limits on recycling withheld shares, no option/SAR reloads or re-pricing without stockholder approval, minimum vesting and performance-period requirements, dividend-equivalent restrictions for certain awards, clawback provisions and double-trigger change-in-control protections. The proposal is contextualized by the company’s recent compensation practices (use of phantom stock due to depletion of prior plan shares) and the Board’s expectation that, if approved, the Compensation Committee will use the Omnibus Plan to grant awards beginning in January 2027. The Board recommends FOR, arguing the Plan is neither excessively dilutive and includes features protective of stockholders. Key risks for investors include dilution from the 300,000-share authorization, discretion retained by the Compensation Committee over award design and adjustments, and potential value transfer to management if performance goals or vesting criteria are not sufficiently rigorous; mitigants include the share limits, anti-repricing provisions and clawback/double-trigger features. For an analyst, evaluating this proposal requires assessing the proposed share pool relative to outstanding shares and burn rates, the specifics of future award designs and performance metrics, and whether the governance protections are likely to prevent outsized awards or inappropriate short-term incentives.
A non-binding, advisory vote to approve the compensation of the company's named executive officers as disclosed in the proxy statement.
This proposal requests a non-binding advisory vote (a ‘say-on-pay’) on the disclosed compensation of the company’s named executive officers. Management asks shareholders to approve the compensation policies and outcomes described in the proxy, emphasizing pay-for-performance design, independent Compensation Committee oversight, use of market benchmarking, a mix of base salary and at-risk short- and long-term incentives, clawback provisions, and double-trigger change-in-control protections. Because the vote is advisory, it does not change compensation directly but signals stockholder support or dissatisfaction; management states it will consider the vote’s outcome when setting future compensation. The context includes recent pay outcomes (STIP and LTIP structures, transition from phantom stock to equity if Omnibus Plan approved, and demonstrated approval in 2025 with over 90% support), and the committee’s use of an independent compensation consultant. The company frames its program as conservative in several ways (modest base salaries, clawbacks, risk controls) but retains significant discretion in award design and performance-goal setting. For analysts, the material issues are whether realized compensation is commensurate with performance, whether long-term incentives have meaningful performance hurdles and stock-based alignment, and whether governance mechanisms (independent committee, consultant, clawbacks) are sufficient to limit excessive risk-taking or misalignment. Management recommends FOR and will take the advisory outcome into account in future program decisions.
To ratify the appointment of Crowe LLP as Citizens’ independent registered public accounting firm for the fiscal year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | WELLINGTON MANAGEMENT GROUP LLP | 6.16% | 593,996 | $12M |
| 2 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 5.02% | 484,188 | $10M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.78% | 461,221 | $9M |
| 4 | DIMENSIONAL FUND ADVISORS LP | 3.45% | 332,372 | $7M |
| 5 | BlackRock, Inc. | 3.08% | 297,307 | $6M |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 2.64% | 254,714 | $5M |
| 7 | GENDELL JEFFREY L | 2.57% | 248,319 | $5M |
| 8 | BANC FUNDS CO LLC | 2.14% | 206,055 | $4M |
| 9 | Boston Partners | 2.06% | 198,361 | $4M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 168,412 | $3M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.